We are live on
!
Find out more
Loomis, Sayles & Company Portfolio holdings
AUM
$74.3B
1-Year Est. Return
24.01%
This Fund
S&P 500
This Quarter
Est. Return
+21.9%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$57.6B
AUM Growth
+$7.69B
(+15%)
Cap. Flow
+$3.7B
Cap. Flow
% of AUM
6.42%
Top 10 Holdings %
Top 10 Hldgs %
40.22%
Holding
1,054
New
202
Increased
277
Reduced
473
Closed
81
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bank of America Series L
BAC.PRL
|
+$3.4B |
| 2 |
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
|
+$885M |
| 3 |
Tesla
TSLA
|
+$252M |
| 4 |
Amazon
AMZN
|
+$156M |
| 5 |
CLVT.PRA
Clarivate Plc 5.25% Series A Mandatory Convertible Preferred Shares
CLVT.PRA
|
+$144M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Novartis
NVS
|
+$379M |
| 2 |
Sherwin-Williams
SHW
|
+$161M |
| 3 |
NVIDIA
NVDA
|
+$154M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$116M |
| 5 |
Boeing
BA
|
+$80M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.6% |
| 2 | Consumer Discretionary | 15.59% |
| 3 | Communication Services | 15.36% |
| 4 | Healthcare | 13.38% |
| 5 | Financials | 10.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
876
Dick's Sporting Goods
DKS
$19.2B
| $4K | ﹤0.01% |
+27
| New | +$3.6K |
|
877
First Horizon
FHN
$12B
| $4K | ﹤0.01% |
240
-393
| -62% | -$8.73K |
|
878
Sarepta Therapeutics
SRPT
$1.81B
| $4K | ﹤0.01% |
28
-107
| -79% | -$13.9K |
|
|
OSH
879
DELISTED
Oak Street Health, Inc.
OSH
| $4K | ﹤0.01% |
+99
| New | +$3.19K |
|
880
Booz Allen Hamilton
BAH
$9.37B
| $3K | ﹤0.01% |
36
-114
| -76% | -$10.8K |
|
881
Erie Indemnity
ERIE
$13.2B
| $3K | ﹤0.01% |
+15
| New | +$3.59K |
|
882
Hubbell
HUBB
$26.7B
| $3K | ﹤0.01% |
14
-51
| -78% | -$12.2K |
|
883
Ollie's Bargain Outlet
OLLI
$4.8B
| $3K | ﹤0.01% |
+58
| New | +$3.19K |
|
884
Principal Financial Group
PFG
$24.4B
| $3K | ﹤0.01% |
+42
| New | +$3.56K |
|
885
RenaissanceRe
RNR
$13.2B
| $3K | ﹤0.01% |
17
+5
| +42% | +$1.01K |
|
886
Ross Stores
ROST
$81.7B
| $3K | ﹤0.01% |
+32
| New | +$3.59K |
|
887
Texas Pacific Land
TPL
$24.2B
| $3K | ﹤0.01% |
18
-45
| -71% | -$9.37K |
|
888
Cboe Global Markets
CBOE
$29.8B
| $2K | ﹤0.01% |
16
-503
| -97% | -$63.1K |
|
889
Commerce Bancshares
CBSH
$8.44B
| $2K | ﹤0.01% |
+36
| New | +$2.01K |
|
890
Church & Dwight Co
CHD
$24.5B
| $2K | ﹤0.01% |
24
-419
| -95% | -$35K |
|
891
CenterPoint Energy
CNP
$26.4B
| $2K | ﹤0.01% |
65
-1,536
| -96% | -$44.9K |
|
892
Campbell Soup
CPB
$6.69B
| $2K | ﹤0.01% |
35
-952
| -96% | -$50.5K |
|
893
Dominion Energy
D
$59.1B
| $2K | ﹤0.01% |
34
-593
| -95% | -$34.7K |
|
894
Amdocs
DOX
$6.22B
| $2K | ﹤0.01% |
23
-3,272
| -99% | -$303K |
|
895
Equinix
EQIX
$103B
| $2K | ﹤0.01% |
3
+1
| +50% | +$704 |
|
896
Extra Space Storage
EXR
$31B
| $2K | ﹤0.01% |
13
+2
| +18% | +$314 |
|
897
FirstEnergy
FE
$27.1B
| $2K | ﹤0.01% |
48
-780
| -94% | -$31.5K |
|
898
Flowers Foods
FLO
$1.51B
| $2K | ﹤0.01% |
69
-1,242
| -95% | -$34.2K |
|
899
Hawaiian Electric Industries
HE
$2.02B
| $2K | ﹤0.01% |
48
-837
| -95% | -$33.9K |
|
900
Hormel Foods
HRL
$13.6B
| $2K | ﹤0.01% |
46
-999
| -96% | -$43.1K |
|
Similar funds
CBU
BC
Loomis, Sayles & Company's Q1 2023 Portfolio in Review
As of Q1 2023, Loomis, Sayles & Company held 1,054 positions worth $57.6B, up 15% from $49.9B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Loomis, Sayles & Company deployed $3.7B of net new capital in Q1 2023, opening 202 new positions and adding to 277 existing holdings. Its largest new stake was Bank of America Series L: 2,835,020 shares worth $81.1M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Communication Services.
On the sell side, the largest reduction was Novartis, an estimated $379M trimmed.
- Loomis, Sayles & Company's largest Q1 2023 buy was Bank of America Series L: 2,835,020 shares worth $81.1M.
- Loomis, Sayles & Company added most to Tesla in Q1 2023, an estimated $252M increase.
- Loomis, Sayles & Company's biggest Q1 2023 reduction was Novartis, cutting an estimated $379M.
- Loomis, Sayles & Company fully exited Globus Medical in Q1 2023, selling an estimated $38M.
- Loomis, Sayles & Company's ten largest holdings make up 40% of its $57.6B portfolio in Q1 2023.
- Loomis, Sayles & Company opened 202 new positions and closed 81 in Q1 2023.
- Loomis, Sayles & Company's portfolio value rose 15% quarter-over-quarter to $57.6B.
Based on Loomis, Sayles & Company's 13F filing for Q1 2023, filed 11 May 2023.